Loading…

Failure of Chemical Thromboprophylaxis in Critically Ill Medical and Surgical Patients with Sepsis

Abstract Purpose Critically ill patients who develop sepsis may be at a higher risk of venous thromboembolism (VTE) prophylaxis failure, however, studies in this population are limited. The objective of this study was to identify the incidence of VTE prophylaxis failure in this population. Methods T...

Full description

Saved in:
Bibliographic Details
Published in:Journal of critical care 2017-02, Vol.37, p.206-210
Main Authors: Hanify, Jennifer M., Pharm.D, Johnson, Donald W., Pharm.D., BCPS, Dupree, Lori H., Pharm.D., BCPS, Ferreira, Jason A., Pharm.D., BCPS
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Purpose Critically ill patients who develop sepsis may be at a higher risk of venous thromboembolism (VTE) prophylaxis failure, however, studies in this population are limited. The objective of this study was to identify the incidence of VTE prophylaxis failure in this population. Methods This retrospective review of patients admitted to the intensive care unit (ICU) between February 2013 and September 2015 included patients who were diagnosed with sepsis and received heparin or enoxaparin VTE prophylaxis. Results Of the 355 patients included, 42 (12.5%) developed a VTE. Acute respiratory distress syndrome (ARDS) (31% vs 16.7%, P = .0272) and higher positive end expiratory pressure (10 vs 8, P = .0066) were associated with increased risk of VTE prophylaxis failure. Logistic regression identified ARDS an event risk factor (OR 2.58, 95% CI 1.22–5.42). VTE was associated with an increased ICU (14 vs 9 days, P = .01) and hospital length of stay (26 vs 15 days, P < .0001). The median time from sepsis diagnosis to VTE event was 9 days (IQR 5–13). Conclusion Critically ill patients with sepsis had a high rate of VTE prophylaxis failure with ARDS being identified as a risk factor for VTE prophylaxis failure.
ISSN:0883-9441
1557-8615
DOI:10.1016/j.jcrc.2016.10.002